Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism (GAPA)
68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling to Determine Treatment in Primary Aldosteronism: A Multicenter Randomized Clinical Trial
Sponsor: Changzhi Medical College
Listed as NCT06238232, this NA trial focuses on Primary Aldosteronism and remains actively recruiting participants. Sponsored by Changzhi Medical College, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Mar 2024 — May 2024 [monthly]
Recruiting NA
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Changzhi Medical College
- Qifu Li
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- The Affiliated Hospital Of Southwest Medical University
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- The First Affiliated Hospital of Zhengzhou University
- The Third Xiangya Hospital of Central South University
- Tongji Hospital
- West China Hospital
- Xiangya Hospital of Central South University
For direct contact, visit the study record on ClinicalTrials.gov .